miRNA-27a-3p and miRNA-222-3p as Novel Modulators of Phosphodiesterase 3a (PDE3A) in Cerebral Microvascular Endothelial Cells

[1]  Wei He,et al.  Upregulation of miR-423 improves autologous vein graft restenosis via targeting ADAMTS-7 , 2019, International journal of molecular medicine.

[2]  Z. Jing,et al.  miR-27a regulates vascular remodeling by targeting endothelial cells' apoptosis and interaction with vascular smooth muscle cells in aortic dissection , 2019, Theranostics.

[3]  Yong Zhou,et al.  The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA , 2019, Journal of clinical medicine.

[4]  Q. Nie,et al.  Circular RNA circHIPK3 Promotes the Proliferation and Differentiation of Chicken Myoblast Cells by Sponging miR-30a-3p , 2019, Cells.

[5]  O. Favorova,et al.  Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission , 2018, Journal of Neuroimmunology.

[6]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[7]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[8]  J. Rapoport,et al.  Erratum: Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells (Cell Reports (2016) 15(5) (1024–1036) (S2211124716303965) (10.1016/j.celrep.2016.03.090)) , 2017 .

[9]  Peiyuan Lv,et al.  Cerebral small vessel disease and post-stroke cognitive impairment , 2017, The International journal of neuroscience.

[10]  Juan Fortea,et al.  Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations , 2017, Molecular Neurobiology.

[11]  Seong-Joon Lee,et al.  Cilostazol improves endothelial function in acute cerebral ischemia patients: a double-blind placebo controlled trial with flow-mediated dilation technique , 2017, BMC Neurology.

[12]  M. Bak,et al.  Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke , 2017, Biomarker Research.

[13]  B. Sharrack,et al.  MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium , 2017, Scientific reports.

[14]  C. Panagiotopoulos,et al.  Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. , 2017, JCI insight.

[15]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[16]  Zong-Lai Jiang,et al.  Secreted miR-27a Induced by Cyclic Stretch Modulates the Proliferation of Endothelial Cells in Hypertension via GRK6 , 2017, Scientific Reports.

[17]  H. Weiner,et al.  Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[18]  F. Setacci,et al.  The use of cilostazol in patients with peripheral arterial disease: results of a national physician survey. , 2016, The Journal of cardiovascular surgery.

[19]  J. Rapoport,et al.  Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells. , 2016, Cell reports.

[20]  Krishna R. Kalari,et al.  BBBomics-Human Blood Brain Barrier Transcriptomics Hub , 2016, Front. Neurosci..

[21]  Subrata Sen,et al.  MicroRNA as Biomarkers and Diagnostics , 2016, Journal of cellular physiology.

[22]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[23]  M. Houslay.  Hypertension linked to PDE3A activation , 2015, Nature Genetics.

[24]  Andreas Busjahn,et al.  PDE3A mutations cause autosomal dominant hypertension with brachydactyly , 2015, Nature Genetics.

[25]  Tetsuya Takahashi,et al.  Endothelial dysfunction is associated with the severity of cerebral small vessel disease , 2015, Hypertension Research.

[26]  J. Pu,et al.  The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis , 2014, BMC Neurology.

[27]  T. Morikawa,et al.  Cilostazol strengthens the endothelial barrier of postcapillary venules from the rat mesentery in situ , 2014, Phlebology.

[28]  Sofie Sølvsten Sørensen,et al.  miRNA Expression Profiles in Cerebrospinal Fluid and Blood of Patients with Acute Ischemic Stroke , 2014, Translational Stroke Research.

[29]  B. Stoica,et al.  Downregulation of miR-23a and miR-27a following Experimental Traumatic Brain Injury Induces Neuronal Cell Death through Activation of Proapoptotic Bcl-2 Proteins , 2014, The Journal of Neuroscience.

[30]  D. Brown,et al.  Systemic Delivery of a miR34a Mimic as a Potential Therapeutic for Liver Cancer , 2014, Molecular Cancer Therapeutics.

[31]  Sophie Rome,et al.  Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization , 2014, Diabetes Care.

[32]  K. Tan,et al.  Molecular Sciences Circulating Micrornas as Biomarkers of Acute Stroke , 2022 .

[33]  K. Blennow,et al.  Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease , 2013, Neurology.

[34]  J. DiNicolantonio,et al.  Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke. , 2013, The American journal of cardiology.

[35]  M. Stoffel,et al.  Miravirsen (SPC3649) can inhibit the biogenesis of miR-122 , 2013, Nucleic acids research.

[36]  P. Couraud,et al.  Cilostazol Strengthens Barrier Integrity in Brain Endothelial Cells , 2013, Cellular and Molecular Neurobiology.

[37]  D. Karolina,et al.  Circulating miRNA profiles in patients with metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[38]  A. Paganini-Hill,et al.  Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties , 2012, Journal of the Neurological Sciences.

[39]  P. Hougaard,et al.  Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression , 2012, Experimental diabetes research.

[40]  Jiatian Cao,et al.  Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. , 2012, Journal of molecular and cellular cardiology.

[41]  C. Lugnier,et al.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments , 2012, British journal of pharmacology.

[42]  A. Ballabio,et al.  Identification of microRNA-regulated gene networks by expression analysis of target genes , 2012, Genome research.

[43]  Andrea Knau,et al.  MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. , 2012, Blood.

[44]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[45]  A. Arboix.  Lacunar infarct and cognitive decline , 2011, Expert review of neurotherapeutics.

[46]  E. Olson,et al.  Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters , 2011, Proceedings of the National Academy of Sciences.

[47]  W. Yuan,et al.  Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration , 2011, Heart.

[48]  Francesca Orso,et al.  microRNA-222 Controls Neovascularization by Regulating Signal Transducer and Activator of Transcription 5A Expression , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[49]  M. McCarthy,et al.  Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes , 2010, Diabetologia.

[50]  Y. Shinohara,et al.  Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[51]  F. Howe,et al.  Blood–brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  Chunxiang Zhang,et al.  A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia , 2009, Circulation research.

[53]  Yinglin,et al.  A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia , 2009 .

[54]  R. Place,et al.  Transient Focal Ischemia Induces Extensive Temporal Changes in Rat Cerebral MicroRNAome , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  Paul A Armitage,et al.  Changes in Background Blood–Brain Barrier Integrity Between Lacunar and Cortical Ischemic Stroke Subtypes , 2008, Stroke.

[56]  A. Armugam,et al.  MicroRNA Expression in the Blood and Brain of Rats Subjected to Transient Focal Ischemia by Middle Cerebral Artery Occlusion , 2008, Stroke.

[57]  Stefanie Dimmeler,et al.  Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.

[58]  Jordan S. Pober,et al.  Dicer Dependent MicroRNAs Regulate Gene Expression and Functions in Human Endothelial Cells , 2007, Circulation research.

[59]  C. Liou,et al.  The phosphodiesterase 4D gene for early onset ischemic stroke among normotensive patients , 2007, Journal of thrombosis and haemostasis : JTH.

[60]  Laura Mariani,et al.  MicroRNAs modulate the angiogenic properties of HUVECs. , 2006, Blood.

[61]  C. Lugnier.  Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. , 2006, Pharmacology & therapeutics.

[62]  M. Matsumoto.  Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study. , 2005, Atherosclerosis. Supplements.

[63]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  S. Kwon,et al.  Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis , 2005, Stroke.

[65]  N. Mochizuki,et al.  Cyclic AMP Potentiates Vascular Endothelial Cadherin-Mediated Cell-Cell Contact To Enhance Endothelial Barrier Function through an Epac-Rap1 Signaling Pathway , 2005, Molecular and Cellular Biology.

[66]  D. Maurice,et al.  Vascular Endothelial Cell Cyclic Nucleotide Phosphodiesterases and Regulated Cell Migration: Implications in Angiogenesis , 2005, Molecular Pharmacology.

[67]  F. Sundler,et al.  β-Cell-targeted Overexpression of Phosphodiesterase 3B in Mice Causes Impaired Insulin Secretion, Glucose Intolerance, and Deranged Islet Morphology* , 2004, Journal of Biological Chemistry.

[68]  J. Olesen,et al.  Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. , 2004, European Journal of Pharmacology.

[69]  A. Terashi,et al.  Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. , 2000, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[70]  Y. Fujito,et al.  Histological characterization of lip and tentacle nerves in Lymnaea stagnalis , 1999, Neuroscience Research.

[71]  A. Malik,et al.  Mechanisms of increased endothelial permeability. , 1996, Canadian journal of physiology and pharmacology.

[72]  J. Rapoport,et al.  Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells. , 2017, Cell reports.

[73]  J. Gamble,et al.  The Poly-cistronic miR-23-27-24 Complexes Target Endothelial Cell Junctions: Differential Functional and Molecular Effects of miR-23a and miR-23b. , 2016, Molecular therapy. Nucleic acids.

[74]  J. Beavo,et al.  Regulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases. , 2011, Handbook of experimental pharmacology.

[75]  A. Verin,et al.  Regulation of endothelial barrier function by the cAMP-dependent protein kinase. , 2000, Endothelium : journal of endothelial cell research.